EDAP to Present at the Jefferies Global Healthcare Conference
EDAP TMS SA (Nasdaq: EDAP), a global leader in robotic energy-based therapies, has announced its participation in the upcoming Jefferies Global Healthcare Conference. CEO Ryan Rhodes will deliver a presentation and conduct one-on-one investor meetings during the conference, scheduled for June 3-5, 2025, in New York City.
Rhodes' presentation is set for Thursday, June 5th, from 4:20-4:50 PM ET. Investors can access both the live and archived webcast of the presentation through the company's website's Investor section or via the provided webcast link.
EDAP TMS SA (Nasdaq: EDAP), leader mondiale nelle terapie robotiche basate sull'energia, ha annunciato la sua partecipazione alla prossima Jefferies Global Healthcare Conference. L'Amministratore Delegato Ryan Rhodes terrà una presentazione e incontrerà investitori in sessioni individuali durante la conferenza, che si svolgerà dal 3 al 5 giugno 2025 a New York City.
La presentazione di Rhodes è prevista per giovedì 5 giugno, dalle 16:20 alle 16:50 ET. Gli investitori potranno seguire la diretta o rivedere la registrazione della presentazione tramite la sezione Investor del sito web della società o attraverso il link per il webcast fornito.
EDAP TMS SA (Nasdaq: EDAP), líder mundial en terapias robóticas basadas en energía, ha anunciado su participación en la próxima Jefferies Global Healthcare Conference. El CEO Ryan Rhodes realizará una presentación y mantendrá reuniones individuales con inversores durante la conferencia, que se llevará a cabo del 3 al 5 de junio de 2025 en la ciudad de Nueva York.
La presentación de Rhodes está programada para el jueves 5 de junio, de 4:20 a 4:50 PM ET. Los inversores podrán acceder a la transmisión en vivo y a la grabación a través de la sección de inversores en el sitio web de la compañía o mediante el enlace proporcionado para el webcast.
EDAP TMS SA (나스닥: EDAP), 에너지 기반 로봇 치료 분야의 글로벌 리더가 다가오는 Jefferies Global Healthcare Conference에 참여한다고 발표했습니다. CEO 라이언 로즈는 2025년 6월 3일부터 5일까지 뉴욕시에서 열리는 컨퍼런스 동안 발표를 하고 1:1 투자자 미팅을 진행할 예정입니다.
로즈의 발표는 6월 5일 목요일 오후 4시 20분부터 4시 50분(동부 표준시)까지 예정되어 있습니다. 투자자들은 회사 웹사이트의 투자자 섹션이나 제공된 웹캐스트 링크를 통해 생중계 및 녹화 방송을 시청할 수 있습니다.
EDAP TMS SA (Nasdaq : EDAP), leader mondial des thérapies robotiques basées sur l'énergie, a annoncé sa participation à la prochaine Jefferies Global Healthcare Conference. Le PDG Ryan Rhodes fera une présentation et tiendra des réunions individuelles avec des investisseurs lors de la conférence, prévue du 3 au 5 juin 2025 à New York.
La présentation de Rhodes est programmée pour le jeudi 5 juin, de 16h20 à 16h50 (heure de l'Est). Les investisseurs pourront accéder au webcast en direct ainsi qu'à son enregistrement via la section Investisseurs du site internet de la société ou via le lien webcast fourni.
EDAP TMS SA (Nasdaq: EDAP), ein weltweit führendes Unternehmen für robotergestützte, energiebasierte Therapien, hat seine Teilnahme an der bevorstehenden Jefferies Global Healthcare Conference angekündigt. CEO Ryan Rhodes wird während der Konferenz, die vom 3. bis 5. Juni 2025 in New York City stattfindet, eine Präsentation halten und Einzelgespräche mit Investoren führen.
Rhodes' Präsentation ist für Donnerstag, den 5. Juni, von 16:20 bis 16:50 Uhr ET geplant. Investoren können die Live-Übertragung sowie die Aufzeichnung der Präsentation über den Investor-Bereich auf der Unternehmenswebsite oder den bereitgestellten Webcast-Link ansehen.
- None.
- None.
AUSTIN, Texas, May 27, 2025 -- EDAP TMS SA (Nasdaq: EDAP) (“the Company”), the global leader in robotic energy-based therapies, today announced that Ryan Rhodes, Chief Executive Officer, is scheduled to deliver a presentation and host 1x1 investor meetings at the Jefferies Global Healthcare Conference, which is being held June 3-5, 2025, in New York City.
Presentation details:
| Date: | Thursday, June 5th |
| Time: | 4:20-4:50 PM ET |
| Webcast: | https://wsw.com/webcast/jeff319/edap/1824368 |
The live and archived webcast of the presentation can be accessed in the Investors section of the Company’s website here.
About EDAP TMS SA
A recognized leader in robotic energy-based therapies, EDAP TMS develops, manufactures, promotes and distributes worldwide minimally invasive medical devices for various conditions using ultrasound technology. By combining the latest technologies in imaging, robotics and precise non-invasive energy delivery, EDAP introduced the Focal One® in Europe and in the U.S. as the leading prostate focal therapy controlled by urologists with the potential to expand to multiple indications beyond prostate cancer. For more information on the Company, please visit https://focalone.com.
Company Contact
Blandine Confort
Investor Relations / Legal Affairs
EDAP TMS SA
+33 4 72 15 31 50
bconfort@edap-tms.com
Investor Contact
John Fraunces
LifeSci Advisors, LLC
(917) 355-2395
jfraunces@lifesciadvisors.com
FAQ
When is EDAP (EDAP) presenting at the Jefferies Global Healthcare Conference 2025?
How can I watch EDAP's (EDAP) presentation at the Jefferies Healthcare Conference?
Who will be representing EDAP (EDAP) at the Jefferies Global Healthcare Conference 2025?
What is EDAP's (EDAP) main business focus?
